Jamie E Chaft Selected Research

Jamie E Chaft Research Topics

Disease

40	Neoplasms (Cancer) 10/2022 - 05/2011
37	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2011
29	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2011
12	Adenocarcinoma of Lung 01/2021 - 09/2012
7	Neoplasm Metastasis (Metastasis) 11/2021 - 02/2014
4	Disease Progression 01/2020 - 10/2011
4	Adenocarcinoma 01/2019 - 02/2012
3	Residual Neoplasm 01/2020 - 12/2017
2	Radiation Pneumonitis 01/2021 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 04/2016
2	Brain Neoplasms (Brain Tumor) 11/2018 - 10/2018
2	Fatigue 10/2018 - 07/2018
2	Pneumonia (Pneumonitis) 07/2018 - 03/2017
1	Human Influenza (Influenza) 01/2021
1	Dyspnea (Shortness of Breath) 10/2018
1	Esophagitis 07/2018
1	Dermatitis 07/2018
1	Body Weight (Weight, Body) 05/2018
1	Myasthenia Gravis 03/2016
1	Pericardial Effusion 03/2016
1	Colitis 03/2016
1	Bullous Pemphigoid (Pemphigoid) 01/2016
1	Breast Neoplasms (Breast Cancer) 02/2014
1	Hemoptysis 08/2013
1	Carcinoma (Carcinomatosis) 09/2012
1	Thymoma (Thymic Carcinoma) 02/2012
1	Sarcoma (Soft Tissue Sarcoma) 02/2012
1	Neuroblastoma 02/2012
1	Carcinogenesis 02/2012
1	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 05/2011

Drug/Important Bio-Agent (IBA)

11	ErbB Receptors (EGF Receptor)IBA 01/2021 - 05/2011
9	durvalumabIBA 01/2022 - 03/2016
8	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2018
8	B7-H1 AntigenIBA 01/2022 - 03/2017
7	Tyrosine Kinase InhibitorsIBA 11/2021 - 10/2011
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 10/2011
5	Proteins (Proteins, Gene)FDA Link 05/2018 - 05/2011
4	Circulating Tumor DNAIBA 12/2020 - 12/2017
4	Monoclonal AntibodiesIBA 02/2018 - 01/2016
3	osimertinibIBA 01/2022 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2013
3	Bevacizumab (Avastin)FDA Link 01/2020 - 08/2013
3	LigandsIBA 02/2018 - 08/2017
3	human ERBB2 proteinIBA 03/2016 - 02/2012
3	Gefitinib (Iressa)FDA Link 12/2012 - 05/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2020
2	PlatinumIBA 01/2021 - 01/2019
2	AfatinibIBA 01/2021 - 12/2015
2	cyclo(Arg-Pro) (CI 4)IBA 01/2021 - 01/2020
2	tremelimumabIBA 12/2020 - 03/2016
2	NivolumabIBA 01/2020 - 05/2018
2	Pharmaceutical PreparationsIBA 12/2018 - 07/2018
2	atezolizumabIBA 11/2018 - 08/2017
2	Pemetrexed (MTA)FDA Link 01/2017 - 04/2016
2	Docetaxel (Taxotere)FDA Link 04/2016 - 10/2013
2	Vinorelbine (Navelbine)FDA LinkGeneric 04/2016 - 10/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2015 - 09/2012
1	Interleukin-7 (Interleukin 7)IBA 01/2021
1	IpilimumabIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	A-factor (Streptomyces)IBA 01/2019
1	SteroidsIBA 10/2018
1	Prednisone (Sone)FDA LinkGeneric 10/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2018
1	AntibodiesIBA 05/2018
1	Thyroid Nuclear Factor 1IBA 01/2017
1	Angiogenesis InhibitorsIBA 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 04/2016
1	Gemcitabine FDA Link 04/2016
1	Lipase (Acid Lipase)FDA Link 03/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	AutoantibodiesIBA 01/2016
1	Epidermal Growth Factor (EGF)IBA 12/2015
1	VaccinesIBA 11/2014
1	NeuroserpinIBA 02/2014
1	SerpinsIBA 02/2014
1	Plasminogen Activator Inhibitor 2IBA 02/2014
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2014
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 02/2014
1	Fibrinolysin FDA Link 02/2014
1	Isoflurophate (DFP)FDA Link 09/2012
1	MAP Kinase Kinase 1IBA 02/2012
1	Anaplastic Lymphoma KinaseIBA 02/2012

Therapy/Procedure

34	Therapeutics 01/2022 - 10/2011
17	Drug Therapy (Chemotherapy) 01/2022 - 10/2011
13	Immunotherapy 01/2022 - 01/2014
8	Adjuvant Chemotherapy 01/2022 - 08/2013
8	Neoadjuvant Therapy 01/2020 - 09/2012
6	Radiotherapy 01/2022 - 01/2017
3	Aftercare (After-Treatment) 01/2020 - 09/2017
2	Precision Medicine 12/2017 - 01/2014
1	Fecal Microbiota Transplantation 10/2022
1	Chemoradiotherapy 01/2021
1	Adrenalectomy 01/2019
1	Metastasectomy 01/2019
1	Retreatment 01/2018
1	Investigational Therapies (Experimental Therapy) 09/2012